These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 28916384)

  • 1. Human Immunodeficiency Virus and Aging in the Era of Effective Antiretroviral Therapy.
    Van Epps P; Kalayjian RC
    Infect Dis Clin North Am; 2017 Dec; 31(4):791-810. PubMed ID: 28916384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aging with HIV in the ART era.
    Kaplan-Lewis E; Aberg JA; Lee M
    Semin Diagn Pathol; 2017 Jul; 34(4):384-397. PubMed ID: 28552209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular health in an aging HIV population.
    Boccara F
    AIDS; 2017 Jun; 31 Suppl 2():S157-S163. PubMed ID: 28471946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Greater burden of chronic comorbidities and co-medications among people living with HIV versus people without HIV in Japan: A hospital claims database study.
    Ruzicka DJ; Imai K; Takahashi K; Naito T
    J Infect Chemother; 2019 Feb; 25(2):89-95. PubMed ID: 30396821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerated aging and human immunodeficiency virus infection: emerging challenges of growing older in the era of successful antiretroviral therapy.
    Bhatia R; Ryscavage P; Taiwo B
    J Neurovirol; 2012 Aug; 18(4):247-55. PubMed ID: 22205585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ageing with HIV: a multidisciplinary review.
    Calcagno A; Nozza S; Muss C; Celesia BM; Carli F; Piconi S; De Socio GV; Cattelan AM; Orofino G; Ripamonti D; Riva A; Di Perri G
    Infection; 2015 Oct; 43(5):509-22. PubMed ID: 25987480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comorbidities and cardiovascular risk factors in an aged cohort of HIV-infected patients on antiretroviral treatment in a Spanish hospital in 2016.
    Fontela C; Castilla J; Juanbeltz R; Martínez-Baz I; Rivero M; O'Leary A; Larrea N; San Miguel R
    Postgrad Med; 2018 Apr; 130(3):317-324. PubMed ID: 29486621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The challenge of polypharmacy in an aging population and implications for future antiretroviral therapy development.
    Smith JM; Flexner C
    AIDS; 2017 Jun; 31 Suppl 2():S173-S184. PubMed ID: 28471948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of the Clinical Pharmacist in the Management of People Living with HIV in the Modern Antiretroviral Era.
    Hill LA; Ballard C; Cachay ER
    AIDS Rev; 2019; 21(4):195-210. PubMed ID: 31834321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of Comorbidities in Treated HIV Infection: A Long Way to Go: HIV, comorbidities and aging.
    Martínez-Sanz J; Serrano-Villar S; Vivancos MJ; Rubio R; Moreno S;
    Int J Antimicrob Agents; 2022 Jan; 59(1):106493. PubMed ID: 34871746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dyslipidaemia and cardiovascular risk in HIV infection.
    Kulasekaram R; Peters BS; Wierzbicki AS
    Curr Med Res Opin; 2005 Nov; 21(11):1717-25. PubMed ID: 16307691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV, aging, and adherence: an update and future directions.
    Mann SC; Castillo-Mancilla JR
    Curr Opin HIV AIDS; 2020 Mar; 15(2):134-141. PubMed ID: 31977338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do people living with HIV experience greater age advancement than their HIV-negative counterparts?
    De Francesco D; Wit FW; Bürkle A; Oehlke S; Kootstra NA; Winston A; Franceschi C; Garagnani P; Pirazzini C; Libert C; Grune T; Weber D; Jansen EHJM; Sabin CA; Reiss P;
    AIDS; 2019 Feb; 33(2):259-268. PubMed ID: 30325781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-related metabolic comorbidities in the current ART era.
    Warriner AH; Burkholder GA; Overton ET
    Infect Dis Clin North Am; 2014 Sep; 28(3):457-76. PubMed ID: 25151566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ageing with HIV: Challenges and biomarkers.
    Rodés B; Cadiñanos J; Esteban-Cantos A; Rodríguez-Centeno J; Arribas JR
    EBioMedicine; 2022 Mar; 77():103896. PubMed ID: 35228014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atherosclerotic Cardiovascular Disease and Anti-Retroviral Therapy.
    Kaplan-Lewis E; Aberg JA; Lee M
    Curr HIV/AIDS Rep; 2016 Oct; 13(5):297-308. PubMed ID: 27562769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV Infection, Antiretroviral Drugs, and the Vascular Endothelium.
    Kanmogne GD
    Cells; 2024 Apr; 13(8):. PubMed ID: 38667287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreasing incidence of herpes zoster in the highly active antiretroviral therapy era.
    Moanna A; Rimland D
    Clin Infect Dis; 2013 Jul; 57(1):122-5. PubMed ID: 23487391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary disease in HIV-infected adults in the era of antiretroviral therapy.
    Fitzpatrick ME; Kunisaki KM; Morris A
    AIDS; 2018 Jan; 32(3):277-292. PubMed ID: 29194119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complementary and Alternative Medicine Among Persons living with HIV in the Era of Combined Antiretroviral Treatment.
    Halpin SN; Carruth EC; Rai RP; Edelman EJ; Fiellin DA; Gibert C; Gordon KS; Huang W; Justice A; Marconi VC; Rimland D; Perkins MM
    AIDS Behav; 2018 Mar; 22(3):848-852. PubMed ID: 28733920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.